Renal Ischaemia Reperfusion Injury: A Mouse Model of Injury and Regeneration
June 7th, 2014
50.7K views
The mouse model of renal ischaemia reperfusion injury described here comprises of a right nephrectomy that provides control tissue and clamping of the left renal pedicle to induce ischaemia that results in acute kidney injury. This model uses a midline laparotomy approach with all steps performed via one incision.
Overview
This article describes a murine model of acute kidney injury induced by ischemia reperfusion injury. The model involves a right nephrectomy for control tissue and clamping of the left renal pedicle to induce ischemia, leading to acute kidney injury.
Key Study Components
Area of Science
- Nephrology
- Renal physiology
- Ischemia reperfusion injury
Background
- Acute kidney injury is a significant clinical problem.
- Ischemia reperfusion injury is a common cause of acute kidney injury.
- Murine models are essential for studying kidney injury and regeneration.
- This model provides a controlled environment to investigate renal responses.
Purpose of Study
- To establish a reliable murine model for studying acute kidney injury.
- To evaluate the effects of ischemia and subsequent reperfusion on kidney function.
- To facilitate research on kidney regeneration mechanisms.
Methods Used
- Midline laparotomy to access the kidneys.
- Right nephrectomy to provide control tissue.
- Clamping of the left renal artery and vein to induce ischemia.
- Restoration of kidney perfusion after a defined ischemic period.
Main Results
- The model successfully induces acute kidney injury.
- Right nephrectomy tissue serves as a useful control.
- Restoration of perfusion leads to observable kidney recovery processes.
- This model can be used for further studies on kidney regeneration.
Conclusions
- The murine model is effective for studying ischemia reperfusion injury.
- It provides insights into both injury mechanisms and recovery.
- This model can aid in the development of therapeutic strategies for acute kidney injury.
Frequently Asked Questions
What is the significance of this study?
This study provides a reliable model for investigating acute kidney injury and regeneration.
How does the model induce ischemia?
Ischemia is induced by clamping the left renal artery and vein.
What is the purpose of the right nephrectomy?
The right nephrectomy serves as a control tissue for comparison.
What are the potential applications of this model?
The model can be used to study kidney injury mechanisms and test therapeutic interventions.
How is kidney perfusion restored?
Kidney perfusion is restored by removing the clamp after a defined ischemic period.
What are the expected outcomes of the study?
Expected outcomes include insights into kidney injury and recovery processes.
Executive Industry Relevance
Reproducible in vivo models of renal ischaemia reperfusion injury (IRI) are essential for de-risking early-stage nephrology drug discovery and for validating mechanistic hypotheses in acute kidney injury (AKI). This mouse model enables precise control of injury severity and supports quantitative assessment of both injury and regeneration, directly informing target validation and translational biomarker strategies. Its versatility across strains, ages, and sexes enhances predictive confidence and portfolio applicability for renal therapeutics.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of molecular and cellular pathways underlying AKI and renal regeneration.
- Supports functional target validation by correlating injury severity with biomarker and histopathological outcomes.
- Facilitates mechanistic de-risking through controlled induction and quantification of renal injury.
Screening & Assay Development
- Provides validated control and injury tissues for downstream biomarker and pharmacodynamic assay development.
- Enables reproducible, quantitative measurement of plasma creatinine and blood urea nitrogen as functional readouts.
- Standardizes injury induction, supporting assay reproducibility and cross-study comparability.
Translational & Preclinical Research
- Aligns with disease-relevant AKI mechanisms observed in clinical settings, enhancing translational continuity.
- Supports evaluation of regenerative processes and candidate interventions over defined time courses.
- Enables risk-adjusted advancement decisions by modeling both injury and recovery phases.
Pipeline & Workflow Integration
This model positions within the early discovery to preclinical continuum, enabling hypothesis testing, target validation, and translational biomarker alignment for renal injury and regeneration programs.
- Discovery Biology: Supports mechanistic studies of AKI and regenerative pathways through controlled injury and recovery.
- Screening: Provides standardized tissues and quantitative readouts for assay development and compound evaluation.
- Analytics: Delivers robust functional (creatinine, BUN) and structural (histopathology) outputs for comparative analysis.
- Translational Research: Models clinically relevant injury and regeneration, supporting biomarker validation and preclinical candidate selection.
- Enterprise Reuse: Applicable across mouse strains, ages, and sexes, enabling broad portfolio integration and cross-program standardization.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target and pathway selection for AKI and renal regeneration.
- Operational Value: Enhances reproducibility and standardization of in vivo renal injury models.
- Strategic Value: Improves go/no-go decision-making and reduces late-stage biological risk in nephrology pipelines.
- Portfolio Impact: Enables risk-adjusted prioritization and cross-program comparability for renal therapeutic candidates.
Implementation Considerations
- Requires expertise in murine surgical techniques and perioperative care.
- Demands access to validated analytical platforms for functional and histological assessment.
- Necessitates rigorous cross-team standardization of injury induction and scoring systems.
- Adaptable to diverse mouse strains, ages, and sexes, supporting broad translational relevance.
- Careful control of ischemia duration and temperature is critical for reproducibility and data integrity.
Biopharma FAQs
Why does null hypothesis testing matter for plasma creatinine analysis?
Null hypothesis testing in plasma creatinine measurements enables objective assessment of renal function changes post-IRI, supporting robust target validation and minimizing false positives in early discovery.
How does independent variable isolation in ischemia duration support discovery?
Isolating ischemia duration as an independent variable allows precise modulation of injury severity, facilitating mechanistic studies and enabling reproducible comparisons across experimental arms.
What do quantitative dependent variable measurements like BUN enable?
Quantitative blood urea nitrogen (BUN) measurements provide functional readouts of renal injury, supporting data-driven evaluation of candidate interventions and translational biomarker development.
Why are replication requirements critical for cross-functional renal studies?
Replication ensures that observed injury and regeneration outcomes are robust and reproducible, enabling reliable cross-functional collaboration and portfolio-level data integration.
Which statistical analysis capabilities are required before implementing histopathology scoring?
Statistical analysis of histopathology scoring requires validated scoring systems and appropriate comparative tests to ensure meaningful interpretation and support decision-making in preclinical research.
